STOCK TITAN

[Form 4] Procter & Gamble Company Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Procter & Gamble (PG) – Form 4 filed 08/07/2025. Chief Operating Officer Shailesh Jejurikar disclosed only acquisitions, no sales of company equity.

  • Direct common stock: 9,982.2858 shares after the transactions.
  • Indirect common stock: 3,301.9815 shares via retirement plan; 19,757 shares in the Sankhya S Jejurikar Revocable Trust; 17,849 shares in the Shailesh Jejurikar Trust.
  • Derivative activity: Four separate grants of Restricted Stock Units (RSUs) and preferred-stock equivalents were reported: 31.0041 RSUs (02/18/25), 33.4003 RSUs (05/15/25), 0.3416 Series A preferred shares convertible into common stock (07/14/25), and 725 RSUs as a retirement award (08/07/25).
  • All entries carry transaction code “A” (acquisition), and each grant was made at $0 cost as part of dividend-equivalent, retirement, or compensation programs.
  • Total derivative holdings following the filing: 494.5685 + 527.9688 + 1,001.0622 + 725 ≈ 2,749 units/shares, split between direct and retirement-plan accounts.

No dispositions, option exercises, or open-market trades were reported; the filing merely updates ownership records and corrects small prior misstatements related to dividend-equivalent RSUs.

Procter & Gamble (PG) – Modulo Form 4 presentato il 07/08/2025. Il Chief Operating Officer Shailesh Jejurikar ha dichiarato solo acquisizioni, nessuna vendita di azioni della società.

  • Azioni ordinarie dirette: 9.982,2858 azioni dopo le transazioni.
  • Azioni ordinarie indirette: 3.301,9815 azioni tramite piano pensionistico; 19.757 azioni nel Sankhya S Jejurikar Revocable Trust; 17.849 azioni nel Shailesh Jejurikar Trust.
  • Attività su strumenti derivati: Sono stati segnalati quattro diversi conferimenti di Restricted Stock Units (RSU) e equivalenti di azioni privilegiate: 31,0041 RSU (18/02/25), 33,4003 RSU (15/05/25), 0,3416 azioni privilegiate Serie A convertibili in azioni ordinarie (14/07/25) e 725 RSU come premio pensionistico (07/08/25).
  • Tutte le voci riportano il codice transazione “A” (acquisizione) e ogni conferimento è stato effettuato a costo zero nell’ambito di programmi di dividendi equivalenti, pensionistici o di compensazione.
  • Totale delle detenzioni in derivati dopo la presentazione: 494,5685 + 527,9688 + 1.001,0622 + 725 ≈ 2.749 unità/azioni, suddivise tra conti diretti e piani pensionistici.

Non sono state segnalate cessioni, esercizi di opzioni o operazioni sul mercato aperto; la presentazione aggiorna semplicemente i registri di proprietà e corregge piccole inesattezze precedenti relative alle RSU di dividendi equivalenti.

Procter & Gamble (PG) – Formulario 4 presentado el 07/08/2025. El Director de Operaciones Shailesh Jejurikar reveló solo adquisiciones, sin ventas de acciones de la empresa.

  • Acciones comunes directas: 9,982.2858 acciones después de las transacciones.
  • Acciones comunes indirectas: 3,301.9815 acciones a través de un plan de jubilación; 19,757 acciones en el Sankhya S Jejurikar Revocable Trust; 17,849 acciones en el Shailesh Jejurikar Trust.
  • Actividad con derivados: Se reportaron cuatro concesiones separadas de Unidades de Acciones Restringidas (RSU) y equivalentes de acciones preferentes: 31.0041 RSU (18/02/25), 33.4003 RSU (15/05/25), 0.3416 acciones preferentes Serie A convertibles en acciones comunes (14/07/25) y 725 RSU como premio de jubilación (07/08/25).
  • Todas las entradas llevan el código de transacción “A” (adquisición), y cada concesión se realizó a costo cero como parte de programas de dividendos equivalentes, jubilación o compensación.
  • Total de participaciones en derivados tras la presentación: 494.5685 + 527.9688 + 1,001.0622 + 725 ≈ 2,749 unidades/acciones, divididas entre cuentas directas y planes de jubilación.

No se reportaron disposiciones, ejercicios de opciones ni operaciones en el mercado abierto; la presentación simplemente actualiza los registros de propiedad y corrige pequeñas declaraciones previas incorrectas relacionadas con RSU equivalentes a dividendos.

Procter & Gamble (PG) – 2025년 8월 7일 제출된 Form 4. 최고운영책임자(Chief Operating Officer) 샤일레시 제주리카(Shailesh Jejurikar)는 회사 주식에 대한 매수만 공개하고, 매도는 없었습니다.

  • 직접 보통주: 거래 후 9,982.2858주.
  • 간접 보통주: 퇴직연금 플랜을 통해 3,301.9815주; Sankhya S Jejurikar Revocable Trust에 19,757주; Shailesh Jejurikar Trust에 17,849주 보유.
  • 파생상품 활동: 제한 주식 단위(RSU)와 우선주 등가물 4건이 보고됨: 31.0041 RSU (2025년 2월 18일), 33.4003 RSU (2025년 5월 15일), 0.3416 주의 A 시리즈 우선주 (보통주 전환 가능, 2025년 7월 14일), 그리고 725 RSU 퇴직 보상 (2025년 8월 7일).
  • 모든 항목은 거래 코드 “A”(취득)를 포함하며, 각 부여는 배당금 상응, 퇴직 또는 보상 프로그램의 일부로 무상으로 이루어졌습니다.
  • 제출 후 총 파생상품 보유량: 494.5685 + 527.9688 + 1,001.0622 + 725 ≈ 2,749 단위/주, 직접 계좌 및 퇴직 플랜 계좌에 분산됨.

처분, 옵션 행사 또는 공개 시장 거래는 보고되지 않았으며, 이번 제출은 소유 기록을 업데이트하고 배당금 상응 RSU와 관련된 이전의 작은 오류를 수정하기 위한 것입니다.

Procter & Gamble (PG) – Formulaire 4 déposé le 07/08/2025. Le directeur des opérations Shailesh Jejurikar a déclaré uniquement des acquisitions, aucune vente d’actions de la société.

  • Actions ordinaires directes : 9 982,2858 actions après les transactions.
  • Actions ordinaires indirectes : 3 301,9815 actions via un plan de retraite ; 19 757 actions dans le Sankhya S Jejurikar Revocable Trust ; 17 849 actions dans le Shailesh Jejurikar Trust.
  • Activité sur dérivés : Quatre attributions distinctes d’Unités d’Actions Restreintes (RSU) et d’équivalents d’actions privilégiées ont été rapportées : 31,0041 RSU (18/02/25), 33,4003 RSU (15/05/25), 0,3416 actions privilégiées de la série A convertibles en actions ordinaires (14/07/25), et 725 RSU en tant que récompense de retraite (07/08/25).
  • Toutes les entrées portent le code de transaction « A » (acquisition), et chaque attribution a été réalisée à coût nul dans le cadre de programmes d’équivalence de dividendes, de retraite ou de rémunération.
  • Total des détentions dérivées après le dépôt : 494,5685 + 527,9688 + 1 001,0622 + 725 ≈ 2 749 unités/actions, réparties entre comptes directs et plans de retraite.

Aucune cession, exercice d’options ou transaction sur le marché ouvert n’a été signalée ; le dépôt met simplement à jour les registres de propriété et corrige de petites erreurs antérieures liées aux RSU équivalents aux dividendes.

Procter & Gamble (PG) – Form 4 eingereicht am 07.08.2025. Chief Operating Officer Shailesh Jejurikar meldete nur Käufe, keine Verkäufe von Unternehmensanteilen.

  • Direkte Stammaktien: 9.982,2858 Aktien nach den Transaktionen.
  • Indirekte Stammaktien: 3.301,9815 Aktien über einen Rentenplan; 19.757 Aktien im Sankhya S Jejurikar Revocable Trust; 17.849 Aktien im Shailesh Jejurikar Trust.
  • Derivative Aktivitäten: Vier separate Zuweisungen von Restricted Stock Units (RSUs) und bevorzugten Aktienäquivalenten wurden gemeldet: 31,0041 RSUs (18.02.25), 33,4003 RSUs (15.05.25), 0,3416 Vorzugsaktien der Serie A, wandelbar in Stammaktien (14.07.25), und 725 RSUs als Ruhestandsauszeichnung (07.08.25).
  • Alle Einträge tragen den Transaktionscode „A“ (Erwerb), und jede Zuweisung erfolgte kostenfrei im Rahmen von Dividendenäquivalent-, Ruhestands- oder Vergütungsprogrammen.
  • Gesamtbestand an Derivaten nach der Meldung: 494,5685 + 527,9688 + 1.001,0622 + 725 ≈ 2.749 Einheiten/Aktien, aufgeteilt auf direkte und Rentenplankonten.

Es wurden keine Veräußerungen, Optionsausübungen oder Börsengeschäfte gemeldet; die Meldung aktualisiert lediglich die Eigentumsaufzeichnungen und korrigiert kleinere frühere Fehler im Zusammenhang mit Dividendenäquivalent-RSUs.

Positive
  • Chief Operating Officer increased beneficial ownership through 725 new RSUs and other small grants, signaling confidence and long-term alignment.
  • No stock sales were reported, removing any immediate overhang concerns.
Negative
  • None.

Insights

TL;DR: Insider added ~789 new RSUs, no sales—signal of continued alignment.

The Form 4 shows Jejurikar accumulating additional equity entirely through grants and dividend equivalents. While the share counts are modest relative to PG’s 2.35 bn shares outstanding, the absence of sales by a senior executive is incrementally positive. RSUs vest on retirement, reinforcing long-term alignment with shareholders. No pricing information or market purchases appear, so direct market sentiment impact is limited, but the steady build in insider ownership removes a potential overhang from executive selling.

TL;DR: Routine compensation grants; corrects minor past errors—corporate-governance neutral.

The filing primarily documents periodic RSU credits and preferred-share accruals under established benefit plans. The corrections to earlier double-counted dividend equivalents are explicitly labeled “immaterial,” indicating robust internal tracking. No red flags such as accelerated vesting, option repricing, or complex related-party structures are present. Governance impact is neutral-to-positive, reflecting transparent disclosure and continued executive stake building.

Procter & Gamble (PG) – Modulo Form 4 presentato il 07/08/2025. Il Chief Operating Officer Shailesh Jejurikar ha dichiarato solo acquisizioni, nessuna vendita di azioni della società.

  • Azioni ordinarie dirette: 9.982,2858 azioni dopo le transazioni.
  • Azioni ordinarie indirette: 3.301,9815 azioni tramite piano pensionistico; 19.757 azioni nel Sankhya S Jejurikar Revocable Trust; 17.849 azioni nel Shailesh Jejurikar Trust.
  • Attività su strumenti derivati: Sono stati segnalati quattro diversi conferimenti di Restricted Stock Units (RSU) e equivalenti di azioni privilegiate: 31,0041 RSU (18/02/25), 33,4003 RSU (15/05/25), 0,3416 azioni privilegiate Serie A convertibili in azioni ordinarie (14/07/25) e 725 RSU come premio pensionistico (07/08/25).
  • Tutte le voci riportano il codice transazione “A” (acquisizione) e ogni conferimento è stato effettuato a costo zero nell’ambito di programmi di dividendi equivalenti, pensionistici o di compensazione.
  • Totale delle detenzioni in derivati dopo la presentazione: 494,5685 + 527,9688 + 1.001,0622 + 725 ≈ 2.749 unità/azioni, suddivise tra conti diretti e piani pensionistici.

Non sono state segnalate cessioni, esercizi di opzioni o operazioni sul mercato aperto; la presentazione aggiorna semplicemente i registri di proprietà e corregge piccole inesattezze precedenti relative alle RSU di dividendi equivalenti.

Procter & Gamble (PG) – Formulario 4 presentado el 07/08/2025. El Director de Operaciones Shailesh Jejurikar reveló solo adquisiciones, sin ventas de acciones de la empresa.

  • Acciones comunes directas: 9,982.2858 acciones después de las transacciones.
  • Acciones comunes indirectas: 3,301.9815 acciones a través de un plan de jubilación; 19,757 acciones en el Sankhya S Jejurikar Revocable Trust; 17,849 acciones en el Shailesh Jejurikar Trust.
  • Actividad con derivados: Se reportaron cuatro concesiones separadas de Unidades de Acciones Restringidas (RSU) y equivalentes de acciones preferentes: 31.0041 RSU (18/02/25), 33.4003 RSU (15/05/25), 0.3416 acciones preferentes Serie A convertibles en acciones comunes (14/07/25) y 725 RSU como premio de jubilación (07/08/25).
  • Todas las entradas llevan el código de transacción “A” (adquisición), y cada concesión se realizó a costo cero como parte de programas de dividendos equivalentes, jubilación o compensación.
  • Total de participaciones en derivados tras la presentación: 494.5685 + 527.9688 + 1,001.0622 + 725 ≈ 2,749 unidades/acciones, divididas entre cuentas directas y planes de jubilación.

No se reportaron disposiciones, ejercicios de opciones ni operaciones en el mercado abierto; la presentación simplemente actualiza los registros de propiedad y corrige pequeñas declaraciones previas incorrectas relacionadas con RSU equivalentes a dividendos.

Procter & Gamble (PG) – 2025년 8월 7일 제출된 Form 4. 최고운영책임자(Chief Operating Officer) 샤일레시 제주리카(Shailesh Jejurikar)는 회사 주식에 대한 매수만 공개하고, 매도는 없었습니다.

  • 직접 보통주: 거래 후 9,982.2858주.
  • 간접 보통주: 퇴직연금 플랜을 통해 3,301.9815주; Sankhya S Jejurikar Revocable Trust에 19,757주; Shailesh Jejurikar Trust에 17,849주 보유.
  • 파생상품 활동: 제한 주식 단위(RSU)와 우선주 등가물 4건이 보고됨: 31.0041 RSU (2025년 2월 18일), 33.4003 RSU (2025년 5월 15일), 0.3416 주의 A 시리즈 우선주 (보통주 전환 가능, 2025년 7월 14일), 그리고 725 RSU 퇴직 보상 (2025년 8월 7일).
  • 모든 항목은 거래 코드 “A”(취득)를 포함하며, 각 부여는 배당금 상응, 퇴직 또는 보상 프로그램의 일부로 무상으로 이루어졌습니다.
  • 제출 후 총 파생상품 보유량: 494.5685 + 527.9688 + 1,001.0622 + 725 ≈ 2,749 단위/주, 직접 계좌 및 퇴직 플랜 계좌에 분산됨.

처분, 옵션 행사 또는 공개 시장 거래는 보고되지 않았으며, 이번 제출은 소유 기록을 업데이트하고 배당금 상응 RSU와 관련된 이전의 작은 오류를 수정하기 위한 것입니다.

Procter & Gamble (PG) – Formulaire 4 déposé le 07/08/2025. Le directeur des opérations Shailesh Jejurikar a déclaré uniquement des acquisitions, aucune vente d’actions de la société.

  • Actions ordinaires directes : 9 982,2858 actions après les transactions.
  • Actions ordinaires indirectes : 3 301,9815 actions via un plan de retraite ; 19 757 actions dans le Sankhya S Jejurikar Revocable Trust ; 17 849 actions dans le Shailesh Jejurikar Trust.
  • Activité sur dérivés : Quatre attributions distinctes d’Unités d’Actions Restreintes (RSU) et d’équivalents d’actions privilégiées ont été rapportées : 31,0041 RSU (18/02/25), 33,4003 RSU (15/05/25), 0,3416 actions privilégiées de la série A convertibles en actions ordinaires (14/07/25), et 725 RSU en tant que récompense de retraite (07/08/25).
  • Toutes les entrées portent le code de transaction « A » (acquisition), et chaque attribution a été réalisée à coût nul dans le cadre de programmes d’équivalence de dividendes, de retraite ou de rémunération.
  • Total des détentions dérivées après le dépôt : 494,5685 + 527,9688 + 1 001,0622 + 725 ≈ 2 749 unités/actions, réparties entre comptes directs et plans de retraite.

Aucune cession, exercice d’options ou transaction sur le marché ouvert n’a été signalée ; le dépôt met simplement à jour les registres de propriété et corrige de petites erreurs antérieures liées aux RSU équivalents aux dividendes.

Procter & Gamble (PG) – Form 4 eingereicht am 07.08.2025. Chief Operating Officer Shailesh Jejurikar meldete nur Käufe, keine Verkäufe von Unternehmensanteilen.

  • Direkte Stammaktien: 9.982,2858 Aktien nach den Transaktionen.
  • Indirekte Stammaktien: 3.301,9815 Aktien über einen Rentenplan; 19.757 Aktien im Sankhya S Jejurikar Revocable Trust; 17.849 Aktien im Shailesh Jejurikar Trust.
  • Derivative Aktivitäten: Vier separate Zuweisungen von Restricted Stock Units (RSUs) und bevorzugten Aktienäquivalenten wurden gemeldet: 31,0041 RSUs (18.02.25), 33,4003 RSUs (15.05.25), 0,3416 Vorzugsaktien der Serie A, wandelbar in Stammaktien (14.07.25), und 725 RSUs als Ruhestandsauszeichnung (07.08.25).
  • Alle Einträge tragen den Transaktionscode „A“ (Erwerb), und jede Zuweisung erfolgte kostenfrei im Rahmen von Dividendenäquivalent-, Ruhestands- oder Vergütungsprogrammen.
  • Gesamtbestand an Derivaten nach der Meldung: 494,5685 + 527,9688 + 1.001,0622 + 725 ≈ 2.749 Einheiten/Aktien, aufgeteilt auf direkte und Rentenplankonten.

Es wurden keine Veräußerungen, Optionsausübungen oder Börsengeschäfte gemeldet; die Meldung aktualisiert lediglich die Eigentumsaufzeichnungen und korrigiert kleinere frühere Fehler im Zusammenhang mit Dividendenäquivalent-RSUs.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jejurikar Shailesh

(Last) (First) (Middle)
ONE PROCTER & GAMBLE PLAZA

(Street)
CINCINNATI OH 45202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PROCTER & GAMBLE Co [ PG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 9,982.2858(1) D
Common Stock 3,301.9815(2) I By Retirement Plan Trustee
Common Stock 19,757 I Sankhya S Jejurikar Revocable Trust
Common Stock 17,849 I Shailesh Jejurikar Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (3) 02/18/2025 A V 31.0041 (4) (4) Common Stock 31.0041 $0 494.5685 D
Restricted Stock Units (3) 05/15/2025 A V 33.4003 (4) (4) Common Stock 33.4003 $0 527.9688(5) D
Series A Preferred Stock (6) 07/14/2025 A V 0.3416 (7) (7) Common Stock 0.3416 $0 1,001.0622 I By Retirement Plan Trustee
Restricted Stock Units (8) 08/07/2025 A 725 (4) (4) Common Stock 725 $0 725 D
Explanation of Responses:
1. Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSUs) settled in stock. The total includes an adjustment in the amount of 57.735 to correct an immaterial error in the number of RSUs due to dividend equivalents that were previously reported twice.
2. Reflects adjustment to PST through July 14, 2025.
3. Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
4. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
5. Total includes an adjustment in the amount of 26.0366 to correct an immaterial error in the number of RSUs due to dividend equivalents that were previously reported twice.
6. Higher of $6.82 (adjusted for 2-for-1 stock split effective May 21, 2004) or market price of Common Stock.
7. Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price.
8. Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.
/s/ Wednesday Shipp, attorney-in-fact for Shailesh Jejurikar 08/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Procter & Gamble (PG) shares does COO Shailesh Jejurikar now hold?

Direct: 9,982.2858 common shares. Indirect: 3,301.9815 via retirement plan, 19,757 and 17,849 through two family trusts.

What new equity did the executive acquire on 08/07/2025?

A retirement award of 725 Restricted Stock Units (RSUs) at no cost, convertible to PG common stock on retirement.

Were any PG shares sold in this Form 4?

No. All transactions were coded “A” for acquisitions; there were no dispositions or option exercises.

Why were some RSU totals adjusted?

Small corrections (57.735 and 26.0366 RSUs) fixed prior double-counting of dividend-equivalent grants; the company labeled these as immaterial.

Do the RSUs vest immediately?

No. The units generally deliver upon retirement unless deferred or contributed to the executive’s compensation account.
Procter & Gamble

NYSE:PG

PG Rankings

PG Latest News

PG Latest SEC Filings

PG Stock Data

358.05B
2.34B
0.06%
70.11%
0.63%
Household & Personal Products
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Link
United States
CINCINNATI